- Home
- AIIO vs OM Comparison
AIIO vs OM Comparison
Compare AIIO & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$0.59
N/A
Current Price
$4.05
Company Overview
Basic Information| Metric | AIIO | OM |
|---|---|---|
| Founded | N/A | 2003 |
| Country | United Arab Emirates | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.2M | 59.2M |
| IPO Year | 2022 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AIIO | OM |
|---|---|---|
| Price | $0.59 | $4.05 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.67 |
| AVG Volume (30 Days) | ★ 1.3M | 106.9K |
| Earning Date | 08-24-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $119,476,000.00 |
| Revenue This Year | N/A | $5.43 |
| Revenue Next Year | N/A | $10.43 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.09 |
| 52 Week Low | $0.07 | $2.84 |
| 52 Week High | $9.20 | $12.97 |
Technical Indicators
Market Signals| Indicator | AIIO | OM |
|---|---|---|
| Relative Strength Index (RSI) | 28.95 | 50.83 |
| Support Level | $0.55 | $3.00 |
| Resistance Level | $1.18 | $4.39 |
| Average True Range (ATR) | 0.08 | 0.31 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 10.13 | 30.23 |
Price Performance
Historical Comparison AIIO
OM
About AIIO Robo.ai Inc. Class B Ordinary Shares
Robo.ai Inc is a technology company dedicated to building an artificial intelligence machine economy platform. Its mission is to integrate smart terminals through AI software, intelligent hardware, and smart assets to construct a unified artificial intelligence operating system and a blockchain-empowered ecosystem to pioneer an intelligent future.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.